Nicotine Gum Market to Expected Cross US$ 2.0 Billion by 2028


Posted May 24, 2023 by imarcservices

The global nicotine gum market size reached US$ 1.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.0 Billion by 2027, exhibiting a growth rate (CAGR) of 5.04% during 2022-2027.

 
The latest research study, “Nicotine Gum Market Share, Size, Growth, Opportunity and Forecast 2022-2027” has been added by IMARC Group. The global nicotine gum market size reached US$ 1.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.0 Billion by 2027, exhibiting a growth rate (CAGR) of 5.04% during 2022-2027.

Nicotine gum has a small amount of nicotine that is absorbed into the bloodstream through the lining of the mouth. It is used as a substitute for cigarettes, which aids smokers in reducing their urge for nicotine intake and overcoming smoking addiction. It should ideally be used with a smoking cessation program, such as support groups, counseling and specific behavioral change techniques, for better results.

Market Trends and Drivers:

Smoking cigarettes can increase the chances of stroke, coronary heart diseases and lung cancer. The growing awareness among individuals about these harmful effects, along with rising health consciousness, represents one of the key factors driving the nicotine gum market growth. In addition to this, governing agencies in several countries are promoting smoking cessation programs. This is attracting new players to invest in the industry. In line with this, various manufactures operating in the industry are also introducing innovative flavors of the product to expand their consumer base. This is anticipated to create a positive impact on the market growth in the coming years.

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

American Tobacco Indus (BTI),
Cambrex Corporation (CBM),
GlaxoSmithKline PLC (GSK),
ITC (ITC.NS),
Johnson & Johnson Services,
Novartis, Perrigo,
Pfizer,
Takeda Pharmaceutical Company, etc.
Request to get the sample report: https://www.imarcgroup.com/nicotine-gum-market/requestsample

Breakup by Type:

2 Mg Nicotine Gum
4 Mg Nicotine Gum
6 Mg Nicotine Gum
Breakup by Application:

Withdrawal Clinics
Medical Practice
Individual Smokers
Others
Breakup by Distribution Channel:

Retail Pharmacies
Specialty Stores
Online Stores
Others
Breakup by Region:

North America
Asia Pacific
Europe
Latin America
Middle East and Africa
Ask An Analyst:- https://www.imarcgroup.com/request?type=report&id=2018&flag=C

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

134 N 4th St.
Brooklyn, NY 11249,
USA
Email: [email protected]
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By IMARC Services
Country India
Categories Fitness , Food , Health
Tags nicotine gum market
Last Updated May 24, 2023